Company Profile
Fulgent Genetics, Inc. Stock Price, News & Catalysts
- Ticker:
- FLGT
- Exchange:
- NASDAQ
- Sector:
- MedTech
- Location:
- United States
Stock performance
24.78 USD (-1.39%)
Close
Last updated: November 19, 2026
531M USD
Market cap
Why the stock is moving
As of Nov 19, 2026, FLGT closed down 1.39% at $24.78. No new same-company headline was identified in the current news window.
Company overview
Precision Medicine Business
Fulgent Genetics operates a laboratory-services business alongside a therapeutic-development portfolio. The company aims to combine diagnostic capabilities with drug development to become an integrated precision-medicine organization.
Laboratory Services
Fulgent provides technical laboratory testing and physician interpretation services. Its operations include genetic and specialty diagnostic capabilities serving healthcare providers, institutions and other customers.
Oncology Therapeutics
The therapeutic business uses nanoencapsulation and targeted-delivery technology to improve the pharmacokinetics and therapeutic window of cancer drugs. Clinical candidates FID-007 and FID-022 represent the lead applications of this platform.
Integrated Diagnostics and Drug Development
The combination of laboratory testing, genomic interpretation and therapeutic research gives Fulgent access to clinical data and operational capabilities across the precision-medicine value chain.
Future catalysts
Recent news
- 01
- 02
- 03
- 04
- 05
Similar stocks
Peer names with similar commercial maturity, therapeutic overlap, or catalyst patterns.
Frequently Asked Questions
What is the current stock price of Fulgent Genetics, Inc. (FLGT)?
Fulgent Genetics, Inc. (FLGT) most recently closed at 24.78 USD, a -1.39% move versus the previous session.
What is the market cap of Fulgent Genetics, Inc. (FLGT)?
Fulgent Genetics, Inc. currently has a market capitalization of 531M USD on BioPharmSignal.
What does Fulgent Genetics, Inc. do?
Precision Medicine Business Fulgent Genetics operates a laboratory-services business alongside a therapeutic-development portfolio. The company aims to combine diagnostic capabilities with drug development to become an integrated precision-medicine organization. Laboratory Services Fulgent provides technical laboratory testing and physician interpretation...
On which exchange is FLGT stock listed?
Fulgent Genetics, Inc. (FLGT) is associated with NASDAQ, United States, MedTech.
What is FID-007?
Clinical candidates FID-007 and FID-022 represent the lead applications of this platform.
Which conditions is Fulgent Genetics, Inc. targeting with FID-007?
Fulgent Genetics, Inc. is associated with oncology, cancer therapeutics, genetic disease based on its company overview and current catalyst commentary.
What is FID-022?
Clinical candidates FID-007 and FID-022 represent the lead applications of this platform.
What is Precision?
Precision Medicine Business Fulgent Genetics operates a laboratory-services business alongside a therapeutic-development portfolio.
